1. Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2Receptor Agonists
   Mojgan Aghazadeh Tabrizi et al, 2016, Chem. Rev. CrossRef
2. Cannabinoid signaling in health and disease
   Yan Lu et al, 2017, Can. J. Physiol. Pharmacol. CrossRef
3. Heparin exerts anti-apoptotic effects on uterine explants by targeting the endocannabinoid system
   Ana Inés Salazar et al, 2016, Apoptosis CrossRef
4. Endocannabinoids as Guardians of Metastasis
   Irmgard Tegeder, 2016, IJMS CrossRef
5. Cannabinoids as Modulators of Cell Death: Clinical Applications and Future Directions.
   B. M. Fonseca et al, 2017 CrossRef
6. Anandamide oxidative metabolism-induced endoplasmic reticulum stress and apoptosis
   M. Almada et al, 2017, Apoptosis CrossRef
7. Medicinal cannabis
   Maria Pettinato, 2017, Nursing CrossRef
8. Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis
   Ester Pagano et al, 2017, Pharmacological Research CrossRef
9. Targeting the endocannabinoid system as a potential anticancer approach
   Rico Schwarz et al, 2018, Drug Metabolism Reviews CrossRef
10. The current state and future perspectives of cannabinoids in cancer biology
    Paweł Śledziński et al, 2018, Cancer Med CrossRef
11. Cannabis medicinal: una guía para enfermeras
    Maria Pettinato, 2018, Nursing (Ed. española) CrossRef
12. Insights into the effects of the endocannabinoid system in cancer: a review
    Ana Isabel Fraguas-Sánchez et al, 2018, British Journal of Pharmacology CrossRef
13. Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells
    Moises Garcia-Arencibia et al, 2018, British Journal of Pharmacology CrossRef
14. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
    Eric P. Baron, 2018, Headache: The Journal of Head and Face Pain CrossRef
15. Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner
    Domenica Roberto et al, 2018, Prostate CrossRef
16. Medical Use of Cannabinoids
    Ana Isabel Fraguas-Sánchez et al, 2018, Drugs CrossRef
17. Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
    Robert Ramer et al, 2019, Front. Pharmacol. CrossRef
18. New approaches to cancer therapy: combining Fatty Acid Amide Hydrolase (FAAH) inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) activation
    Leonardo Brunetti et al, 2019, J. Med. Chem. CrossRef
19. The Use of Medical Marijuana in Cancer
    Shauna M. Birdsall et al, 2016, Curr Oncol Rep CrossRef
20. Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas
    A. I. Fraguas-Sánchez et al, 2016, Expert Opinion on Investigational Drugs CrossRef
21. Cannabinoids as Anticancer Drugs
    Robert Ramer et al, 2017 CrossRef
22. Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis
    Pedro Melgar-Lesmes et al, 2019, Cells CrossRef
23. Treatment with Cannabinoids as a Promising Approach for Impairing Fibroblast Activation and Prostate Cancer Progression
    null Pietrovito et al, 2020, IJMS CrossRef
24. The Endocannabinoid System: A Target for Cancer Treatment
    Chiara Laezza et al, 2020, IJMS CrossRef
25. Involvement of Metabolic Lipid Mediators in the Regulation of Apoptosis
    Piotr Wójcik et al, 2020, Biomolecules CrossRef
26. Cannabinoids as anticancer therapeutic agents.
    Olga Kovalchuk et al, 2020, Cell Cycle CrossRef
27. The heterogeneity and complexity of Cannabis extracts as antitumor agents
    Liran Baram et al, 2019, Oncotarget CrossRef
28. Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human osteosarcoma
    Francesca Punzo et al, 2017, Oncotarget CrossRef
29. Endocannabinoid system and the expression of endogenous ceramides in human hepatocellular carcinoma
    Jiayong Yang et al, 2019, Oncol Lett CrossRef
30. Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies
    Kanika Singh et al, 2020, IJMS CrossRef
31. Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors
    Leonardo Brunetti et al, 2020, IJMS CrossRef
32. New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis.
    Hector Contreras Muñoz, 0 CrossRef
33. The Interplay between Cancer Biology and the Endocannabinoid System—Significance for Cancer Risk, Prognosis and Response to Treatment
    Estefanía Moreno et al, 2020, Cancers CrossRef
34. Synthesis and Evaluation of the Novel Prostamide, 15-Deoxy, Δ12,14-Prostamide J2, as a Selective Antitumor Therapeutic
    Daniel A. Ladin et al, 2017, Mol Cancer Ther CrossRef
35. Therapeutic potential of cannabinoids in combination cancer therapy
    Pratibha Malhotra et al, 2021, Advances in Biological Regulation CrossRef
36. ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro.
    Özge Boyacıoğlu et al, 2021, Cell Death Dis CrossRef
37. Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System—Implications for Health and Disease
    Estefanía Moreno et al, 2021, IJMS CrossRef
38. Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways
    Kun Wang et al, 2021, BioMed Research International CrossRef
39. The Monoacylglycerol Lipase Inhibitor JZL184 Inhibits Lung Cancer Cell Invasion and Metastasis via the CB₁ Cannabinoid Receptor.
    Jan Lukas Prüser et al, 2021, Mol Cancer Ther CrossRef
40. Intrinsic drug potential of oxazolo[5,4‐ d ]pyrimidines and oxazolo[4,5‐ d ]pyrimidines
    Victor V. Zhirnov et al, 2021, Chem Biol Drug Des CrossRef
41. Cannabinoids in the landscape of cancer.
    Nagina Mangal et al, 2021, J Cancer Res Clin Oncol CrossRef
42. The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer
    Kanika Singh et al, 2021, Cancers CrossRef
43. TIBBİ KENEVİR VE SAĞLIK: FARMAKOLOJİK BİR DERLEME
    Özge BALPINAR NALCI et al, 2021 CrossRef
44. Diverse role of endocannabinoid system in mammalian male reproduction
    Tahseen S. Sayed et al, 2021, Life Sciences CrossRef
45. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics
    Gerhard Nahler, 2022, Pharm Med CrossRef
46. Uporaba kanabinoidov v medicinske namene: Ali so pritiski javnosti in laikov utemeljeni?
    Tadeja Kuret, 2022, alt CrossRef
47. Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death
    Amal M. Shoeib et al, 2022, IJMS CrossRef
48. Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials
    Nazeer Hasan et al, 2022, Journal of Drug Targeting CrossRef
49. Anti-cancer activities of Schedule E1 drugs used in ayurvedic formulations
    E.N.T. Vikram et al, 2022, Journal of Ayurveda and Integrative Medicine CrossRef
50. Anti-Tumorigenic Effect of a Novel Derivative of 2-Hydroxyoleic Acid and the Endocannabinoid Anandamide on Neuroblastoma Cells
    Hana Golan et al, 2022, Biomedicines CrossRef
51. Antimicrobial and Cytotoxic Effects of Cannabinoids: An Updated Review with Future Perspectives and Current Challenges
    Mansab Ali Saleemi et al, 2022, Pharmaceuticals CrossRef
52. The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
    Ivona Maria Tudorancea et al, 2022, Biomedicines CrossRef
53. Endocannabinoids and related compounds as modulators of angiogenesis: Concepts and clinical significance
    Shima Afshar et al, 2022, Cell Biochemistry & Function CrossRef
54. Cannabinoids as Prospective Anti-Cancer Drugs: Mechanism of Action in Healthy and Cancer Cells
    Özge Boyacıoğlu et al, 2022 CrossRef
55. The Effect of Cannabis Plant Extracts on Head and Neck Squamous Cell Carcinoma and the Quest for Cannabis-Based Personalized Therapy
    Kifah Blal et al, 2023, Cancers CrossRef
56. The evolution of cannabinoid receptors in cancer
    Nakea M. Pennant et al, 2023, WIREs Mechanisms of Disease CrossRef
57. The Plant Derived 3-3′-Diindolylmethane (DIM) Behaves as CB2 Receptor Agonist in Prostate Cancer Cellular Models
    Paolo Tucci et al, 2023, IJMS CrossRef
58. Cannabidiol and Cannabis Sativa as a potential treatment in vitro prostate cancer cells silenced with RBBp6 and PC3 xenograft
    Lesetja R. Motadi et al, 2023, Mol Biol Rep CrossRef
59. Anti-Tumor Effects of Cannabinoids in Brain, Lung, Breast, Prostate, Colorectal, and Pancreatic Cancers
    Dhairavi Shah et al, 2022 CrossRef
60. Could cannabinoids provide a new hope for ovarian cancer patients?
    Rimanee Kaur et al, 2023, Pharmacology Res & Perspec CrossRef
61. In Vitro Antiproliferative Effect of Cannabis Extract PHEC-66 on Melanoma Cell Lines
    Ava Bachari et al, 2023, Cells CrossRef
62. Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment
    Ava Bachari et al, 2023, WIREs Mechanisms of Disease CrossRef
63. Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches
    Marta Iozzo et al, 2021, Cells CrossRef
64. Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management.
    Siddharth A Shah et al, 2021, J Cancer Res Ther CrossRef